Cargando…

Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease

SIMPLE SUMMARY: The incidence of hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD) has increased in recent years. Compared to HCC caused by other chronic liver diseases, NAFLD-related HCC is often detected later, because it more commonly arises before cirrhosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Son, Koen C., Verschuren, Lars, Hanemaaijer, Roeland, Reeves, Helen, Takkenberg, R. Bart, Drenth, Joost P. H., Tushuizen, Maarten E., Holleboom, Adriaan G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954729/ https://www.ncbi.nlm.nih.gov/pubmed/36831649 http://dx.doi.org/10.3390/cancers15041308

Ejemplares similares

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey
por: Driessen, Stan, et al.
Publicado: (2023)

Systematic Review with Meta-Analyses: Diagnostic Accuracy of FibroMeter Tests in Patients with Non-Alcoholic Fatty Liver Disease
por: Van Dijk, Anne-Marieke, et al.
Publicado: (2021)

The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
por: Houttu, Veera, et al.
Publicado: (2020)

Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
por: Grobbee, Esmée J., et al.
Publicado: (2022)

The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
por: Grefhorst, Aldo, et al.
Publicado: (2021)

Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Houttu, Veera, et al.
Publicado: (2021)

Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis
por: Houttu, Veera, et al.
Publicado: (2022)

Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis
por: Peters, Kia M., et al.
Publicado: (2018)

A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?
por: Betzel, Bark, et al.
Publicado: (2014)

Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
por: Weiskirchen, Ralf, et al.
Publicado: (2019)

Key Inflammatory Processes in Human NASH Are Reflected in Ldlr(−/−).Leiden Mice: A Translational Gene Profiling Study
por: Morrison, Martine C., et al.
Publicado: (2018)

All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells
por: Werner, Melanie, et al.
Publicado: (2015)

New onset non‐alcoholic fatty liver disease after resection of pancreatic neuroendocrine tumors
por: Mackay, Tara Michella, et al.
Publicado: (2018)

Non-infectious Parenchymal Lung Disease
por: Dalpiaz, G., et al.
Publicado: (2016)

Parenchymal pericytes are not the major contributor of extracellular matrix in the fibrotic scar after stroke in male mice
por: Roth, Michaela, et al.
Publicado: (2019)

An In Vitro Human Liver Model by iPSC-Derived Parenchymal and Non-parenchymal Cells
por: Koui, Yuta, et al.
Publicado: (2017)

Metabolic-associated Fatty Liver Disease as Assessed by the Fatty Liver Index Among Migrant and Non-migrant Ghanaian Populations
por: van Dijk, Anne-Marieke, et al.
Publicado: (2021)

Isolation and co-culture of rat parenchymal and non-parenchymal liver cells to evaluate cellular interactions and response
por: Bale, Shyam Sundhar, et al.
Publicado: (2016)

Interaction of non-parenchymal hepatocytes in the process of hepatic fibrosis
por: Cheng, Qi-Ni, et al.
Publicado: (2021)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis
por: van den Hoek, Anita M., et al.
Publicado: (2022)

Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update
por: Dorairaj, Vicneswarry, et al.
Publicado: (2020)

A Pathogenic Role of Non-Parenchymal Liver Cells in Alcohol-Associated Liver Disease of Infectious and Non-Infectious Origin
por: Kharbanda, Kusum K., et al.
Publicado: (2023)

Human non-parenchymal liver cells for co-cultivation systems
por: Ghallab, Ahmed
Publicado: (2014)

Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach
por: Stols-Gonçalves, Daniela, et al.
Publicado: (2023)

Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell
por: Tavares-Valente, Diana, et al.
Publicado: (2023)

Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Mak, Anne Linde, et al.
Publicado: (2021)

Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease
por: Schaapman, Jelte J., et al.
Publicado: (2020)

Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer
por: Li, Qing, et al.
Publicado: (2022)

Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease
por: Troelstra, Marian A., et al.
Publicado: (2022)

Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
por: Zachou, Kalliopi, et al.
Publicado: (2023)

Tacrolimus 4‐hour monitoring in liver transplant patients is non‐inferior to trough monitoring: The randomized controlled FK04 trial
por: Ruijter, Bastian N., et al.
Publicado: (2022)

Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease
por: Newman, Lauren A., et al.
Publicado: (2020)

Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells
por: Gart, Eveline, et al.
Publicado: (2021)

Development and maintenance of the brain's immune toolkit: Microglia and non‐parenchymal brain macrophages
por: Lopez‐Atalaya, Jose P., et al.
Publicado: (2017)

Unresolved issues in hepatitis C: The role of liver non-parenchymal cells and semaphorins
por: Vince, Adriana, et al.
Publicado: (2018)

Distinct Features of Brain-Resident Macrophages: Microglia and Non-Parenchymal Brain Macrophages
por: Lee, Eunju, et al.
Publicado: (2021)

A Complicated Parenchymal-Esophageal Fistula in Non-Small Cell Lung Cancer
por: AlTarawneh, Saba, et al.
Publicado: (2022)

A hepatoprotective role of peritumoral non-parenchymal cells in early liver tumorigenesis
por: Tian, Cheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_chq7ifrs5qmrspahgj6ad4fhfh